EP3116600A4 - Compositions and methods comprising sirtuins - Google Patents

Compositions and methods comprising sirtuins Download PDF

Info

Publication number
EP3116600A4
EP3116600A4 EP15760722.7A EP15760722A EP3116600A4 EP 3116600 A4 EP3116600 A4 EP 3116600A4 EP 15760722 A EP15760722 A EP 15760722A EP 3116600 A4 EP3116600 A4 EP 3116600A4
Authority
EP
European Patent Office
Prior art keywords
sirtuins
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP15760722.7A
Other languages
German (de)
French (fr)
Other versions
EP3116600A1 (en
Inventor
Joseph D. Ceccoli
Brian R. COSTELLO
Sanford R. Simon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocogent LLC
Original Assignee
Biocogent LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocogent LLC filed Critical Biocogent LLC
Publication of EP3116600A1 publication Critical patent/EP3116600A1/en
Publication of EP3116600A4 publication Critical patent/EP3116600A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP15760722.7A 2014-03-11 2015-03-11 Compositions and methods comprising sirtuins Withdrawn EP3116600A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461951256P 2014-03-11 2014-03-11
PCT/US2015/019971 WO2015138607A1 (en) 2014-03-11 2015-03-11 Compositions and methods comprising sirtuins

Publications (2)

Publication Number Publication Date
EP3116600A1 EP3116600A1 (en) 2017-01-18
EP3116600A4 true EP3116600A4 (en) 2017-08-23

Family

ID=54072368

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15760722.7A Withdrawn EP3116600A4 (en) 2014-03-11 2015-03-11 Compositions and methods comprising sirtuins

Country Status (3)

Country Link
EP (1) EP3116600A4 (en)
CN (1) CN106573156A (en)
WO (1) WO2015138607A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1508328A1 (en) * 2003-08-22 2005-02-23 L'oreal Composition against the degradation of fibres of collagen induced in condition of natural solar exposure
WO2006103352A1 (en) * 2005-04-01 2006-10-05 Societe D'extraction Des Principes Actifs Sa (Vincience) Use of compounds inducing synthesis of sirt proteins in or for preparing a cosmetic or pharmaceutical compositions
FR2906139A1 (en) * 2006-09-21 2008-03-28 Davines France Sarl Binary treatment to fight against the signs of skin aging and to eliminate undesirable cell growth, comprises applying a night formulation to stimulate and/or activate sirtuins and applying a day formulation to inhibit the same sirtuins
US20110059526A1 (en) * 2008-11-12 2011-03-10 Nupotential, Inc. Reprogramming a cell by inducing a pluripotent gene through use of an hdac modulator

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2529510A1 (en) * 2003-07-01 2005-01-13 President And Fellows Of Harvard College Compositions for manipulating the lifespan and stress response of cells and organisms
US20100144885A1 (en) * 2006-09-29 2010-06-10 The Board Of Trustees Of The University Of Illinois Histone acetyl transferase activators and histone deacetylase inhibitors in the treatment of alcoholism
CN102985553B (en) * 2010-04-15 2015-11-25 西特里斯药业公司 Sirtuin activator and activation determination
FR2966040A1 (en) * 2010-10-19 2012-04-20 Brigitte Gourlaouen SLIMMING COMPOSITION AND / OR PREVENTING INFLAMMATORY PROCESSES

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1508328A1 (en) * 2003-08-22 2005-02-23 L'oreal Composition against the degradation of fibres of collagen induced in condition of natural solar exposure
WO2006103352A1 (en) * 2005-04-01 2006-10-05 Societe D'extraction Des Principes Actifs Sa (Vincience) Use of compounds inducing synthesis of sirt proteins in or for preparing a cosmetic or pharmaceutical compositions
FR2906139A1 (en) * 2006-09-21 2008-03-28 Davines France Sarl Binary treatment to fight against the signs of skin aging and to eliminate undesirable cell growth, comprises applying a night formulation to stimulate and/or activate sirtuins and applying a day formulation to inhibit the same sirtuins
US20110059526A1 (en) * 2008-11-12 2011-03-10 Nupotential, Inc. Reprogramming a cell by inducing a pluripotent gene through use of an hdac modulator

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
DATABASE GNPD [online] MINTEL; 18 October 2012 (2012-10-18), ANONYMOUS: "Skin Adrenaline Anti-Aging Concentrate", XP055527061, retrieved from www.gnpd.com Database accession no. 1913715 *
DATABASE GNPD [online] MINTEL; December 2013 (2013-12-01), "Proenergetic Face Serum", XP002771826, Database accession no. 2252272 *
DATABASE GNPD [online] MINTEL; January 2013 (2013-01-01), "Firming Mask", XP002771828, Database accession no. 1968938 *
DATABASE GNPD [online] MINTEL; March 2012 (2012-03-01), "Anti-Ageing Eye Treatment", XP002771827, Database accession no. 1754827 *
DATABASE GNPD [online] MINTEL; September 2011 (2011-09-01), "Breakout Solution", XP002771829, Database accession no. 1626638 *
DATABASE GNPD [online] MINTEL; September 2013 (2013-09-01), "CC Cream Time release Tinted Treatment SPF 30", XP002771830, Database accession no. 2156516 *
See also references of WO2015138607A1 *
SHALOME BASSETT ET AL: "The Role of Dietary Histone Deacetylases (HDACs) Inhibitors in Health and Disease", NUTRIENTS, vol. 6, no. 10, 15 October 2014 (2014-10-15), pages 4273 - 4301, XP055527117, DOI: 10.3390/nu6104273 *

Also Published As

Publication number Publication date
CN106573156A (en) 2017-04-19
EP3116600A1 (en) 2017-01-18
WO2015138607A1 (en) 2015-09-17

Similar Documents

Publication Publication Date Title
EP3151846A4 (en) Methods and compositions for nuclease design
GB2535253B (en) Compositions and methods
EP3188749A4 (en) Tolerogenic compositions and methods
EP3190894A4 (en) Microbial compositions and methods
EP3233052A4 (en) Suncare compositions and methods
EP3209142A4 (en) Lysolecithin compositions and their use
EP3099171A4 (en) Dihydropteridinone derivatives and uses thereof
EP3179983A4 (en) Anti-methanogenic compositions and uses thereof
EP3131636A4 (en) Curcumin compositions and uses thereof
EP3197279A4 (en) Antimicrobial compositions and methods
EP3125905A4 (en) Methods and compositions for microbiome alteration
EP3096757A4 (en) Apilimod compositions and methods for using same
GB201417828D0 (en) New methods and compositions
EP3166892A4 (en) Scale-inhibition compositions and methods of making and using the same
EP3102339A4 (en) Nano-tribology compositions and related methods including molecular nano-sheets
EP3198275A4 (en) Sterilization compositions and methods
EP3191114A4 (en) Occidiofungin formulations and uses thereof
EP3177147A4 (en) Dihydropteridinone derivatives and uses thereof
EP3190886A4 (en) Compositions and methods of use thereof
EP3139741A4 (en) Methods and compositions comprising 10-hydroxy-2-decenoic acid
EP3193878A4 (en) Compounds and methods
EP3213769A4 (en) Transdermal-absorption-promoter and transdermal-absorption-promoting supplement
EP3093296A4 (en) Fuc3s4s substituted oligoglycosaminoglycan and preparation method thereof
EP3137479A4 (en) Oligonucleotide compositions and methods of making the same
EP3148564A4 (en) Methods and compositions for immunomodulation

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20161011

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 8/66 20060101ALI20170713BHEP

Ipc: A61K 8/64 20060101ALI20170713BHEP

Ipc: A61Q 19/08 20060101AFI20170713BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20170721

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20181130

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20190130